Vertex Pharmaceuticals (NASDAQ: VRTX) and Mirum Pharmaceuticals (NASDAQ: MIRM) are two biotech stocks that share the same ...
Inside the deadly disease confounding medicine, researchers piecing together clues and the breakthrough that meant survival ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...
Vertex Pharmaceuticals' business will suffer if other drugmakers launch competing cystic fibrosis drugs. Despite this threat, ...
A computational study shows for the first time how different parts of the human airway experience levels of pressure and ...
In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a ...
Families grappling with the challenges of a loved one diagnosed with incurable diseases have more than enough to handle in ...
I’ve spent my life navigating cystic fibrosis alongside anxiety, OCD, and depression — struggles that once led me to numb everything with alcohol until a wake‑up call changed everything. Through ...
Dr Uta Hill joins the Clinical Excellence in Respiratory Care speaker line-up to discuss adult cystic fibrosis services and ...
The FDA has expanded indications for two targeted combination treatments, Alyftrek and Trikafta, that will now benefit more individuals with cystic fibrosis, according to a press release from the ...
Sign up for the Concord Monitor’s morning newsletter for essential news each day, and our contests and promotions list for special offers and giveaways. To his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results